|
Cours en clôture
11/09/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
6,630 CNY
|
-1,63%
|
 |
-0,45%
|
+2,16%
|
|
01/08 |
Shanxi Yabao Pharmaceutical Logistics Distribution Co., Ltd. announced that it expects to receive CNY 50 million in funding from Yabao Pharmaceutical Group Co., Ltd
| | |
01/08 |
Beijing Yabao Biopharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from Yabao Pharmaceutical Group Co., Ltd
| | |
31/07 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026
| | |
31/07 |
Yabao Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 200 million worth of its shares.
| | |
31/07 |
Yabao Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
| | |
25/05 |
Yabao Pharmaceutical Subsidiary Secures Chinese Regulatory Approval for High Cholesterol Tablets
| | |
24/04 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
24/04 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
22/12 |
Shanxi Tongxiang Times Technology Co., Ltd. completed the acquisition ofan additional 62% stake in Yabao Pharmaceutical Taiyuan Pharmaceutical Co., Ltd. from Yabao Pharmaceutical Group Co., Ltd.
| | |
18/12 |
Yabao Pharma Gets Clinical Trial Nod for Pulmonary Arterial Hypertension Drug
| | |
17/11 |
Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 17, 2025.
| | |
14/11 |
Yabao Pharmaceutical Group Co., Ltd's Equity Buyback announced on May 17, 2025, has closed with 8,000,000 shares, representing 1.14% for CNY 52.15 million.
| | |
13/11 |
Yabao Pharmaceutical Obtains Registration for Children's Nutrition Product
| | |
24/10/25 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
09/10/25 |
Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 17, 2025.
| | |
24/09/25 |
Yabao Pharmaceutical Gets Nod to Trial Asthma Drug for Children
| | |
23/09/25 |
Yabao Pharmaceutical Ends Trial for Diabetes Drug; Shares Down 3%
| | |
15/08/25 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
06/08/25 |
Yabao Pharmaceutical to Buy Rights of Chaiqin Ningshen Granules for 22 Million Yuan; Shares Down 3%
| | |
19/05/25 |
Yabao Pharmaceutical's Propranolol Hydrochloride Tablets Passes Regulator's Consistency Evaluation
| | |
17/05/25 |
Yabao Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.
| | |
28/04/25 |
Yabao Pharmaceutical Group Co., Ltd announces Annual dividend, payable on May 30, 2025
| | |
25/04/25 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
25/04/25 |
Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
24/04/25 |
Yabao Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
